BTIS
BIVV

BB&T Investment Services’s Bioverativ Inc. Common Stock BIVV Stock Holding History

BB&T Investment Services’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$27K Buy
+592
New +$32.4K ﹤0.01% 720
2017
Q3 		– Sell
-366
Closed -$23K – 1366
2017
Q2 		$23K Sell
366
-59
-14% -$3.36K 0.01% 641
2017
Q1 		$21K Buy
+425
New +$20.9K 0.01% 558

Other funds holding BIVV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

BB&T Investment Services's BIVV Position: Q4 2017 in Review

BB&T Investment Services opened a new position in Bioverativ Inc. Common Stock (BIVV) in Q4 2017: 592 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #720 among its holdings. This is a return to the name: BB&T Investment Services previously reported a position in BIVV as recently as Q2 2017.

BB&T Investment Services first reported a position in BIVV in Q1 2017 and has held it in 3 quarters since. 459 funds tracked by Wall St. Rank hold BIVV as of Q4 2017.

  • BB&T Investment Services held 592 shares of Bioverativ Inc. Common Stock worth $27K as of Q4 2017.
  • Bioverativ Inc. Common Stock was a new BB&T Investment Services position in Q4 2017.
  • Bioverativ Inc. Common Stock made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #720 holding.
  • BB&T Investment Services first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and has held it in 3 quarters since.
  • 459 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.